S&P 500   4,075.39 (-0.12%)
DOW   34,279.31 (-0.90%)
QQQ   291.73 (-0.56%)
AAPL   147.35 (-0.46%)
MSFT   252.39 (-1.08%)
META   119.60 (+1.27%)
GOOGL   100.73 (-0.26%)
AMZN   95.49 (-1.09%)
TSLA   195.19 (+0.25%)
NVDA   168.92 (-0.18%)
NIO   12.18 (-4.69%)
BABA   86.19 (-1.56%)
AMD   76.91 (-0.93%)
T   19.22 (-0.31%)
MU   55.52 (-3.69%)
CGC   3.66 (+1.10%)
F   14.15 (+1.80%)
GE   85.13 (-0.98%)
DIS   96.98 (-0.91%)
AMC   7.63 (+5.53%)
PYPL   78.34 (-0.09%)
PFE   50.67 (+1.08%)
NFLX   316.76 (+3.68%)
S&P 500   4,075.39 (-0.12%)
DOW   34,279.31 (-0.90%)
QQQ   291.73 (-0.56%)
AAPL   147.35 (-0.46%)
MSFT   252.39 (-1.08%)
META   119.60 (+1.27%)
GOOGL   100.73 (-0.26%)
AMZN   95.49 (-1.09%)
TSLA   195.19 (+0.25%)
NVDA   168.92 (-0.18%)
NIO   12.18 (-4.69%)
BABA   86.19 (-1.56%)
AMD   76.91 (-0.93%)
T   19.22 (-0.31%)
MU   55.52 (-3.69%)
CGC   3.66 (+1.10%)
F   14.15 (+1.80%)
GE   85.13 (-0.98%)
DIS   96.98 (-0.91%)
AMC   7.63 (+5.53%)
PYPL   78.34 (-0.09%)
PFE   50.67 (+1.08%)
NFLX   316.76 (+3.68%)
S&P 500   4,075.39 (-0.12%)
DOW   34,279.31 (-0.90%)
QQQ   291.73 (-0.56%)
AAPL   147.35 (-0.46%)
MSFT   252.39 (-1.08%)
META   119.60 (+1.27%)
GOOGL   100.73 (-0.26%)
AMZN   95.49 (-1.09%)
TSLA   195.19 (+0.25%)
NVDA   168.92 (-0.18%)
NIO   12.18 (-4.69%)
BABA   86.19 (-1.56%)
AMD   76.91 (-0.93%)
T   19.22 (-0.31%)
MU   55.52 (-3.69%)
CGC   3.66 (+1.10%)
F   14.15 (+1.80%)
GE   85.13 (-0.98%)
DIS   96.98 (-0.91%)
AMC   7.63 (+5.53%)
PYPL   78.34 (-0.09%)
PFE   50.67 (+1.08%)
NFLX   316.76 (+3.68%)
S&P 500   4,075.39 (-0.12%)
DOW   34,279.31 (-0.90%)
QQQ   291.73 (-0.56%)
AAPL   147.35 (-0.46%)
MSFT   252.39 (-1.08%)
META   119.60 (+1.27%)
GOOGL   100.73 (-0.26%)
AMZN   95.49 (-1.09%)
TSLA   195.19 (+0.25%)
NVDA   168.92 (-0.18%)
NIO   12.18 (-4.69%)
BABA   86.19 (-1.56%)
AMD   76.91 (-0.93%)
T   19.22 (-0.31%)
MU   55.52 (-3.69%)
CGC   3.66 (+1.10%)
F   14.15 (+1.80%)
GE   85.13 (-0.98%)
DIS   96.98 (-0.91%)
AMC   7.63 (+5.53%)
PYPL   78.34 (-0.09%)
PFE   50.67 (+1.08%)
NFLX   316.76 (+3.68%)
OTCMKTS:PBSV

Pharma-Bio Serv - PBSV Stock Forecast, Price & News

$0.77
0.00 (0.00%)
(As of 11/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.77
$0.77
50-Day Range
$0.77
$0.97
52-Week Range
$0.58
$1.10
Volume
N/A
Average Volume
1,014 shs
Market Capitalization
$18.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PBSV stock logo

About Pharma-Bio Serv (OTCMKTS:PBSV) Stock

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil. Its technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Stock News Headlines

PharmAbcine to Participate in BIO-Europe 2022
PBSV: Slow and steady wins the race.
Brazil's Biolab buys Canada's Exzell Pharma
Expert Ratings for Biomarin Pharmaceutical
PBSV: Lowering target; still a solid value
Pharma-Bio Serv reports Q2 results
What 4 Analyst Ratings Have To Say About Biomarin Pharmaceutical
See More Headlines
Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Company Calendar

Last Earnings
9/14/2022
Today
12/01/2022
Fiscal Year End
10/31/2023

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
N/A
Current Symbol
OTCMKTS:PBSV
Employees
190
Year Founded
N/A

Profitability

Net Income
$-2,090,000.00
Pretax Margin
-18.86%

Debt

Sales & Book Value

Annual Sales
$20.11 million
Book Value
$0.81 per share

Miscellaneous

Free Float
20,526,000
Market Cap
$18.18 million
Optionable
Not Optionable
Beta
0.34

Key Executives

  • Mr. Victor Sanchez (Age 51)
    CEO, Pres & Pres of European Operations
    Comp: $346.55k
  • Ms. Elizabeth Plaza (Age 58)
    Founder & Sr. Strategic Consultant
    Comp: $69.92k
  • Mr. Pedro J. Lasanta (Age 62)
    CFO, VP of Fin. & Admin. and Sec.
    Comp: $250.6k
  • Ms. Miriam Marrero M.B.A.
    HR Mang.













PBSV Stock - Frequently Asked Questions

How have PBSV shares performed in 2022?

Pharma-Bio Serv's stock was trading at $1.03 at the start of the year. Since then, PBSV stock has decreased by 24.8% and is now trading at $0.7750.
View the best growth stocks for 2022 here
.

How were Pharma-Bio Serv's earnings last quarter?

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) announced its quarterly earnings data on Wednesday, September, 14th. The company reported $0.01 EPS for the quarter. The company earned $4.77 million during the quarter. Pharma-Bio Serv had a negative net margin of 19.85% and a negative trailing twelve-month return on equity of 23.63%.

How often does Pharma-Bio Serv pay dividends? What is the dividend yield for Pharma-Bio Serv?

Pharma-Bio Serv announced a dividend on Friday, February 18th. Shareholders of record on Friday, February 25th will be paid a dividend of $0.075 per share on Tuesday, March 15th. This represents a yield of 16.13%. The ex-dividend date of this dividend is Thursday, February 24th.
Read our dividend analysis for PBSV
.

What other stocks do shareholders of Pharma-Bio Serv own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pharma-Bio Serv investors own include Zynerba Pharmaceuticals (ZYNE), Allena Pharmaceuticals (ALNA), AstroNova (ALOT), Oracle (ORCL), AT&T (T), Yintech Investment (YIN), Aeglea BioTherapeutics (AGLE), Ampliphi Biosciences (APHB), Carnival Co. & (CCL) and Earthstone Energy (ESTE).

What is Pharma-Bio Serv's stock symbol?

Pharma-Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV."

How do I buy shares of Pharma-Bio Serv?

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pharma-Bio Serv's stock price today?

One share of PBSV stock can currently be purchased for approximately $0.77.

How much money does Pharma-Bio Serv make?

Pharma-Bio Serv (OTCMKTS:PBSV) has a market capitalization of $18.18 million and generates $20.11 million in revenue each year. The company earns $-2,090,000.00 in net income (profit) each year or ($0.18) on an earnings per share basis.

How many employees does Pharma-Bio Serv have?

The company employs 190 workers across the globe.

How can I contact Pharma-Bio Serv?

Pharma-Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The official website for the company is www.pharmabioserv.com. The company can be reached via phone at (787) 278-2709, via email at scottg@corprominence.com, or via fax at 787-796-5168.

This page (OTCMKTS:PBSV) was last updated on 12/1/2022 by MarketBeat.com Staff